Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJardine Math.sr Regulatory News (JAR)

Share Price Information for Jardine Math.sr (JAR)

Share Price is delayed by 15 minutes
Get Live Data
62.50    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: $18.42b
JAR Live PriceLast checked at - London Stock Exchange

Intraday Jardine Math.sr Share Chart

Interim Management Statement

18 May 2023 10:23

RNS Number : 8917Z
Mandarin Oriental International Ltd
18 May 2023
Β 

Announcement

Β 

The following announcement was issued today to a Regulatory Information Service approved by the Financial Conduct Authority in the United Kingdom.

Β 

MANDARIN ORIENTAL INTERNATIONAL LIMITED

Interim Management Statement

Β 

18th May 2023 - Mandarin Oriental International Limited today issues its Interim Management Statement for the first quarter of 2023.

Β 

The Group recorded an underlying profit in the first quarter of 2023, driven by improved performance from both the Group's owned hotels and its management business. RevPAR grew substantially in Asia compared to last year, as the region benefitted from the removal of travel restrictions. As a result, the Group's owned hotels saw a significantly improved performance, particularly in Hong Kong, Tokyo, and Bangkok. In the rest of the world, our hotels were also able to achieve a higher RevPAR compared to both last year and 2019, driven by strong rates.

Β 

The first quarter saw progress on a number of hotel developments. In January, the Group announced a new management contract for a luxury beach resort in Mallorca, Spain, scheduled to open by the end of 2024. In February, after three years' work, the Emirates Palace hotel in Abu Dhabi was rebranded as Emirates Palace Mandarin Oriental, Abu Dhabi. In March, Mandarin Oriental, Singapore, closed for a substantial renovation; it is expected to reopen in September 2023.

Β 

As a result of improved trading conditions, the Group generated underlying earnings before interest, tax, depreciation, and amortisation ('EBITDA') of US$30 million, a substantial increase from the EBITDA loss of US$1 million in the first quarter of 2022. Owned hotels reported an EBITDA of US$19 million, with almost all hotels delivering increased financial performance. The management business saw significant growth and generated higher fees, with hotels, particularly in Hong Kong and Mainland China, contributing to an EBITDA of US$7 million. Unaudited underlying profit in the first quarter was US$3 million, much improved from an underlying loss of US$26 million in 2022.

Β 

The Group's redevelopment project in Causeway Bay, Hong Kong, formerly the site of The Excelsior hotel, is ongoing, in line with our budget, and is expected to complete in early 2025.

Β 

Consolidated net debt as at 31st March 2023 reduced to US$311 million (US$376 million at 31st December 2022). The Group's liquidity position remains robust, with US$453 million in available committed debt facilities and US$306 million of cash reserves. Gearing was 6% of adjusted shareholders' funds.

Β 

On 2nd May 2023, the Company announced that Laurent Kleitman would replace James Riley as Group Chief Executive of Mandarin Oriental International Limited with effect from 1st September 2023.

Β 

Mandarin Oriental International Limited is incorporated in Bermuda and has a primary listing in the standard segment of the London Stock Exchange, with secondary listings in Bermuda and Singapore. Mandarin Oriental is a member of the Jardine Matheson Group.

Β 

- end -

Β 

For further information, please contact:

Β 

Mandarin Oriental Hotel Group International Limited

James Riley

(852) 2895 9288

Matthew Bishop

(852) 2895 9288

Β 

Brunswick Group Limited

William Brocklehurst

(852) 5685 9881

Β 

This and other Group announcements can be accessed online at 'www.mandarinoriental.com'.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
DOCKVLBFXELLBBB
Date   Source Headline
3rd Jun 202510:20 amRNSDirector/PDMR Shareholding
30th May 202510:23 amRNSTotal Voting Rights
29th May 202510:23 amRNSDirectorate Change
23rd May 202511:27 amRNSInterim Management Statement
23rd May 202511:01 amRNSBoard Changes
22nd May 202511:19 amRNSINTERIM MANAGEMENT STATEMENT
21st May 202510:26 amRNSDirector/PDMR Shareholding
19th May 202511:23 amRNSINTERIM MANAGEMENT STATEMENT
16th May 202510:33 amRNSDirector/PDMR Shareholding
15th May 202511:44 amRNSINTERIM MANAGEMENT STATEMENT
14th May 202511:03 amRNSTotal Voting Rights
8th May 202510:48 amRNSAdditional Listing
2nd May 20251:00 pmRNSResult of AGM
30th Apr 202512:24 pmRNSJC&C Interim Management Statement
30th Apr 202512:20 pmRNSPT Astra 2025 First Quarter Financial Statements
30th Apr 202510:58 amRNSPT DFI Retail Nusantara Tbk 3 Months 2025 Results
30th Apr 202510:31 amRNSDividend
25th Apr 202511:22 amRNSDividend
7th Apr 202510:22 amRNSAnnual Financial Report
2nd Apr 202510:31 amRNSCirc re. Scrip Dividend Scheme
28th Mar 20259:53 amRNSDirector/PDMR Shareholding
25th Mar 20259:48 amRNSBlock listing Interim Review
17th Mar 20259:41 amRNSDirector/PDMR Shareholding
13th Mar 202511:15 amRNSPT DFI RETAIL NUSANTARA TBK FULL YEAR 2024 RESULTS
10th Mar 202512:07 pmRNS2024 PRELIMINARY RESULTS
10th Mar 20259:46 amRNS2024 PRELIMINARY RESULTS
7th Mar 202512:13 pmRNS2024 PRELIMINARY RESULTS
5th Mar 20251:42 pmRNS2024 PRELIMINARY RESULTS
27th Feb 20251:13 pmRNSJC&C - 2024 FY Results and Dividend
27th Feb 202512:28 pmRNSPT Astra – 2024 Full Year Financial Statements
24th Feb 20259:23 amRNSDirectorate Change
31st Jan 20259:16 amRNSTotal Voting Rights
21st Jan 20259:51 amRNSHolding(s) in Company
13th Jan 202512:09 pmRNSTransaction in Own Shares
10th Jan 20257:00 amRNSTransaction in Own Shares
11th Dec 202410:08 amRNSDirectorate Changes
10th Dec 20249:27 amRNSHolding(s) in Company
14th Nov 20249:49 amRNSInterim Management Statement
14th Nov 20249:43 amRNSINTERIM MANAGEMENT STATEMENT
14th Nov 20249:42 amRNSINTERIM MANAGEMENT STATEMENT
14th Nov 20249:42 amRNSINTERIM MANAGEMENT STATEMENT
13th Nov 20249:46 amRNSJC&C Interim Management Statement
31st Oct 202410:17 amRNSTotal Voting Rights
31st Oct 20249:26 amRNSPT Hero Supermarket Tbk Nine Months 2024 Results
30th Oct 202410:23 amRNSPT Astra 2024 Third Quarter Financial Statements
30th Oct 20249:29 amRNSDirector/PDMR Shareholding
29th Oct 202410:33 amRNSDirector/PDMR Shareholding
25th Oct 202410:34 amRNSDirector/PDMR Shareholding
18th Oct 202410:33 amRNSDirector/PDMR Shareholding
9th Oct 202411:27 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.